about
Evaluation of spontaneous propulsive movement as a screening tool to detect rescue of Parkinsonism phenotypes in zebrafish models.Median tests for censored survival data; a contingency table approach.Variable selection in subdistribution hazard frailty models with competing risks data.Hierarchical likelihood inference on clustered competing risks data.The Influence of Knee Pain Location on Symptoms, Functional Status, and Knee-related Quality of Life in Older Adults With Chronic Knee Pain: Data From the Osteoarthritis Initiative.Rank tests for clustered survival data when dependent subunits are randomized.Application of smoothing methods to evaluate treatment-prognostic factor interactions in breast cancer data.A parametric model for long-term follow-up data from phase III breast cancer clinical trials.A new generalization of Weibull distribution with application to a breast cancer data set.Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation.Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer.Trastuzumab plus adjuvant chemotherapy for human epidermal growth factor receptor 2-positive breast cancer: planned joint analysis of overall survival from NSABP B-31 and NCCTG N9831.Regression on quantile residual life.Empirical likelihood ratio test for median and mean residual lifetimeBreast cancer adjuvant therapy: time to consider its time-dependent effects.Intrinsic subtypes, PIK3CA mutation, and the degree of benefit from adjuvant trastuzumab in the NSABP B-31 trial.Time-Varying Effects of Breast Cancer Adjuvant Systemic TherapySeven-year follow-up assessment of cardiac function in NSABP B-31, a randomized trial comparing doxorubicin and cyclophosphamide followed by paclitaxel (ACP) with ACP plus trastuzumab as adjuvant therapy for patients with node-positive, human epiderBody Mass Index at Diagnosis and Breast Cancer Survival Prognosis in Clinical Trial Populations from NRG Oncology/NSABP B-30, B-31, B-34, and B-38.Low-Fidelity Haptic Simulation Versus Mental Imagery Training for Epidural Anesthesia Technical Achievement in Novice Anesthesiology Residents: A Randomized Comparative Study.Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in patients treated by breast-conserving therapy in five National Surgical Adjuvant Breast and Bowel Project protocols of node-negative breast cancerSigns and symptoms that differentiate acute sinusitis from viral upper respiratory tract infectionEvaluation of microtubule-associated protein-Tau expression as a prognostic and predictive marker in the NSABP-B 28 randomized clinical trialPredicting degree of benefit from adjuvant trastuzumab in NSABP trial B-31.Stationary versus agitated storage of whole blood during acute normovolemic hemodilution.Predicting response to antimicrobial therapy in children with acute sinusitis.A first look at the Accreditation Council for Graduate Medical Education anesthesiology milestones: implementation of self-evaluation in a large residency program.Overexpression of Glut-1 and increased glucose metabolism in tumors are associated with a poor prognosis in patients with oral squamous cell carcinoma.Competing events and costs of clinical trials: Analysis of a randomized trial in prostate cancer.Detection of recurrent oral squamous cell carcinoma by [18F]-2-fluorodeoxyglucose-positron emission tomography: implications for prognosis and patient management.Treatment of lymph-node-negative, oestrogen-receptor-positive breast cancer: long-term findings from National Surgical Adjuvant Breast and Bowel Project randomised clinical trials.Patterns of locoregional failure in patients with operable breast cancer treated by mastectomy and adjuvant chemotherapy with or without tamoxifen and without radiotherapy: results from five National Surgical Adjuvant Breast and Bowel Project randomTreatment of axillary lymph node-negative, estrogen receptor-negative breast cancer: updated findings from National Surgical Adjuvant Breast and Bowel Project clinical trials.Benefit from exemestane as extended adjuvant therapy after 5 years of adjuvant tamoxifen: intention-to-treat analysis of the National Surgical Adjuvant Breast And Bowel Project B-33 trial.Censored quantile regression for residual lifetimes.Nonparametric inference on median residual life function.Amenorrhea from Breast Cancer Therapy — Not a Matter of DosePopulation-Based Study of Competing Mortality in Head and Neck CancerPitfalls of Using Composite Primary End Points in the Presence of Competing RisksOverexpression of GLUT-1 is associated with resistance to radiotherapy and adverse prognosis in squamous cell carcinoma of the oral cavity
P50
Q30463109-1AA958FF-B97B-449F-A885-87F66BEE1CB4Q30578740-DC76E261-4406-4CA3-808F-24ED98F79A81Q30837437-88E1D510-98A1-4AC2-A2A2-63ECC287138EQ30987625-67258151-714D-41BD-AF46-951E4C0B0961Q30989902-5888D800-E7EB-4045-A67C-E8B6C4914D98Q31004452-8EAF3E94-E655-4DA8-932A-A5CB45C980D8Q31047548-29250957-718C-43EA-AD69-CDF74BD1BC6AQ33185723-C32BFF2F-8955-4E02-846D-A1C87B73FABCQ33441482-E030607C-7D04-4D2A-BB7C-D072589E7BB6Q34145639-6B516147-FCA9-449C-BE0D-8948FE25AC85Q34155828-AB4934F5-E0A5-4C1D-A905-24BA5FEE759DQ34484185-86E9BCB5-B1C1-4557-AD3D-7108D6E29B43Q34630187-CA26D7BC-026A-4982-909C-99F02B74E694Q34731308-4EF6305D-B01B-46CE-9984-5C9AD6A731DDQ35023428-810A6EC3-F9AD-4855-A95A-61AC739C4147Q35419840-0BABBD4D-D484-459A-BEB2-85D5B7039D9AQ36255577-9FE55F58-0E94-4EFF-B375-6D53841BE9EBQ36339698-1E3D58E3-57F9-46E1-AAF1-871FA642EDE2Q36463767-E6B2D8F5-42A9-48AE-8531-0C6F127F1DF3Q36823278-8ED46061-E191-456F-9B2E-1516C60B923EQ37198977-335D92CD-7CB3-4CE2-BA15-B95A00380EFEQ37247881-DC2928AB-8CC6-44B5-BE22-7C02F8387DB6Q37347500-FA8C387E-E285-4C54-AEFF-62C5B2605B8EQ37360367-BF9A1B2C-0EEA-4BF1-8005-D57512848926Q37523546-575531B3-A87E-49E7-96E1-67BB0DD40E1AQ37620149-61F8C2A7-B2AF-41CB-A73B-1CF0340B7082Q39690513-8C57C3F0-C346-4EA8-93E5-917EF66BEB21Q44304223-C9DD5D8B-FEF8-4A54-91EF-25C56828270DQ44378219-552E3A44-1555-4870-B711-CCE8634F7199Q44644593-9A04EDF8-8F07-4AE6-997D-82B38B6ED01BQ45046869-E387A601-53D6-48A1-969E-681D39FB51F8Q45081463-61AE3AE0-CFFC-422F-B6F8-DE76A530670AQ45188723-378456E1-ACB5-4267-AAC5-4C128B255CE5Q46708743-0E0F71D3-2ED7-4C01-A898-B68AAC5F456CQ51468731-18E12B3A-22BA-4DDD-B236-E23EC0138E53Q51914573-233B22E2-5D1F-4ABB-8542-9DF7D325CE36Q61624798-BE891AD3-8B34-4064-B15A-8CBFA6BD86D8Q62071387-2779E319-C280-40F4-AB0A-584E1E6818E0Q62071396-5B1400E1-C1BC-4A80-BB1A-6C6987B945EFQ79506613-AFEC2402-EB2E-4489-8DF0-A7B77631D019
P50
description
researcher
@en
name
Jong-Hyeon Jeong
@en
Jong-Hyeon Jeong
@nl
type
label
Jong-Hyeon Jeong
@en
Jong-Hyeon Jeong
@nl
prefLabel
Jong-Hyeon Jeong
@en
Jong-Hyeon Jeong
@nl
P106
P31
P496
0000-0003-0596-2201